Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 1

Status

Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 3Papillomavirus Infections 2Vulvar Diseases 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2384Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1831Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1016Vincristine 964Cetuximab 945Trastuzumab 944Prednisone 941Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
artenimol × Clear all
NCT06075264 2025-08-14

ART-VIN IIB

Frantz Viral Therapeutics, LLC

Phase 2 Recruiting
27 enrolled
Gynecologic

Vulvar Diseases, Papillomavirus Infections

NCT05555862 2025-05-18

anal HSIL HIV-

Frantz Viral Therapeutics, LLC

Phase 2 Active not recruiting
17 enrolled

Papillomavirus Infections

NCT06417099 2025-04-23

Efficacy of Dihydroartemisinin for Treating PCOS

Shanghai Zhongshan Hospital

Phase 2 Completed
30 enrolled

Polycystic Ovary Syndrome

NCT06842524 2025-04-20

Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome

Shanghai Zhongshan Hospital

Phase 2 Recruiting
150 enrolled

Polycystic Ovary Syndrome

NCT05465135 2024-05-17

The Effect of Dihydroartemisinin in PCOS

Shanghai Zhongshan Hospital

Phase 4 Completed
19 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡